Open Access

Capsaicin induces apoptosis in MG63 human osteosarcoma cells via the caspase cascade and the antioxidant enzyme system

  • Authors:
    • Won Ho Cho
    • Hyun Joo Lee
    • Yoon Ji Choi
    • Joo Han Oh
    • Han Soo Kim
    • Hwan Seong Cho
  • View Affiliations

  • Published online on: October 17, 2013     https://doi.org/10.3892/mmr.2013.1737
  • Pages: 1655-1662
  • Copyright: © Cho et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Osteosarcoma is the most common malignant bone tumor in children and adolescents. This aggressive cancer mostly occurs in the long bones. Therefore, novel therapeutic approaches, such as biological therapies and gene therapy, are required to efficiently treat osteosarcoma. Capsaicin (trans‑8‑methyl‑N‑vanillyl‑6‑nonenamide) has been demonstrated to inhibit the growth of several types of cancer cells and a number of studies have shown that osteosarcoma may be vulnerable to biological therapies. However, little is known regarding the therapeutic effects of capsaicin on osteosarcoma. This study investigated the effects of capsaicin on MG63 human osteosarcoma cells, in addition to elucidating the regulatory signaling pathways underlying the effects of capsaicin, the caspase cascade and the antioxidant enzyme system. The MG63 cell line was treated with various concentrations of capsaicin. Cells were analyzed using MTT and flow cytometry, and the presence of DNA fragmentation was evaluated using TUNEL assay. Results showed capsaicin induced apoptosis in MG63 cells. Thus, capsaicin exhibited an anticancer effect in osteosarcoma cells.

Introduction

Previous studies focused on developing novel reagents that exhibit anticarcinogenic and antimutagenic properties in a number of types of cancer (13). Capsaicin (trans-8- methyl-N-vanillyl-6-nonenamide) is an important pungent ingredient with a spicy flavor that is widely used, and may be extracted from chili peppers of the genus Capsicum(4,5). It has been demonstrated that capsaicin is able to inhibit the growth of various types of cancer cells, such as human hepatoma carcinoma (6), human colon cancer (7), human breast cancer (8) and human neuroblastoma (9) cells.

Osteosarcoma is the most common malignant bone tumor in children and adolescents (10). This aggressive cancer mostly occurs in the long bones. For the past two decades, chemotherapy and surgery have been commonly used as therapies to improve the condition of patients with osteosarcoma. However, the major problems associated with such intense chemotherapies have increased, with a number of patients showing no improvement in their condition, as a result of the development of resistance against the treatment, and some even presenting with serious side effects in other organs of the body (1114). Accordingly, novel therapeutic approaches, such as biological therapies and gene therapy, are required to efficiently treat osteosarcoma.

A number of studies have shown that osteosarcoma may be vulnerable to biological therapies (1517); however, little is known with regard to the therapeutic effects of capsaicin on osteosarcoma. This study examined the effects of capsaicin on MG63 human osteosarcoma cells using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, flow cytometry, western blot analysis and terminal deoxynucleotidyltransferase-mediated deoxyuridine triphosphate (dUTP) nick end-labelling (TUNEL) assay. In addition, the study explored the regulatory signaling pathway underlying the effects of capsaicin, using a variety of inhibitors.

Materials and methods

Reagents

Capsaicin and MTT were purchased from Sigma-Aldrich (St. Louis, MO, USA), while Dulbecco's modified Eagle's medium (DMEM), phosphate-buffered saline (PBS) and fetal bovine serum (FBS) were obtained from Invitrogen Life Technologies (Carlsbad, CA, USA). The U0126, PD98053, SP600125 and Z-VAD-FMK used in the study were purchased from Calbiochem® (Merck KGaA, Darmstadt, Germany) and a chemiluminescence (ECL) kit was obtained from Amersham Pharmacia Biotech (GE Healthcare, Amersham, UK). Bcl-2, Bcl-2-associated X protein (Bax) and pro-caspase-3 were obtained from Epitomics, Inc. (Burlingame, CA, USA), while phosphorylated extracellular signal-regulated kinase (p-ERK), phosphorylated p-38 (p-p38) and phosphorylated c-Jun N-terminal kinase (p-JNK) were purchased from Cell Signaling Technology, Inc. (Beverly, MA, USA).

Cell line and culture conditions

MG63 cells (human osteosarcoma cell line) were purchased from the Korean Cell Line Bank (Seoul, Korea) and cultured in DMEM containing 10% heat-inactivated FBS. The cells were plated in tissue culture dishes at 37°C in a humidified 5% CO2 incubator and cultured for 2–4 days until confluence was reached. Subcultures were prepared using 0.05% trypsin solution and seeded in 6- or 96-well tissue culture plates. Serum was starved from the culture media at the time of adding various agents.

Measurement of cell growth by MTT

Cell viability was assessed using an MTT assay, based on the reduction of MTT into formazan dye by the action of mitochondrial enzymes. MG63 cells were seeded in 96-well plates at a density of 5×102 cells per well and indicated concentrations of capsaicin were added for indicated time-periods. Briefly, following treatment with capsaicin at various concentrations (0, 50, 100, 150, 200, 250 and 400 μM) and various time-periods (0, 3, 6, 12, 24 and 48 h) under 150 μM of capsaicin, the cells were washed and 0.5 mg/ml MTT in DMEM solution was added to each well, prior to incubation for 2 h at 37°C. The supernatant was then removed and the cells were dissolved in dimethylsulfoxide (DMSO). The absorbance of each well was measured at 570 nm with a 680 microplate enzyme-linked immunosorbent assay (ELISA) reader (Bio-Rad Laboratories, Hemel Hempstead, UK).

Cell morphology

The untreated and treated cells were seeded in 6-well plates at a density of 5×104 cells per well and incubated for 24 h with 50–400 μM capsaicin (0, 50, 100, 150, 200, 250 and 400 μM). Cell morphology was examined under a light microscope.

Flow cytometric analysis

Cells were seeded in 6-well plates at a density of 5×104 cells per well and treated with the indicated reagents for 24 h at 37°C. The suspended and adherent cells were then harvested using 0.05% trypsin solution. The harvested cells were centrifuged at 10,000 × g for 15 min at 4°C and the pellets were then washed in PBS, prior to the addition of fixing solution with ice-cold 100% ethanol containing 0.25% Triton X-100 for treatment overnight at 4°C. Subsequent to fixation, the cells were washed and stained with 50 μg/ml propidium iodide containing 100 μg/ml RNase, prior to being incubated for 20 min at 37°C and analyzed using a FACSort flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA).

TUNEL assay

The presence of DNA fragmentation was evaluated using TUNEL assay with an in situ Cell Death Detection kit (fluorescein) from Roche Applied Science (Indianapolis, IN, USA). The cells were seeded in cover slides (5×102 cells per slide) and then treated with capsaicin. Following this, the cells were washed in PBS and freshly prepared 4% paraformaldehyde was added for cell fixation for 1 h at 37°C in a humidified 5% CO2 incubator. The cells were then washed again in PBS, prior to being permeabilized in permeabilization solution (0.1% Triton X-100 in 0.1% sodium citrate) for 2 min on ice. The cells were then subjected to the TUNEL reaction at 37°C in a humidified atmosphere in the dark for 60 min. The fluorescence signal emitted by the fluorescein-labeled dUTP incorporated into the fragmented DNA was detected using Leica confocal microscopy (Leica Microsystems, Wetzlar, Germany).

Measurement of cell death using the trypan blue dye exclusion assay

Capsaicin-treated cells were harvested using 0.05% trypsin solution and then suspended with 0.4% trypan blue solution. The cells were counted using a hemocytometer under a light microscope and cells that were observed to exclude the dye were considered viable.

Western blot analysis

The cells were seeded in 6-well plates at a density of 5×104 cells/cm2, cultured and incubated in DMEM containing 10% FBS. Prior to treatment with the indicated conditions, the cells were serum-starved overnight, treated with the agent and then harvested. Using lysis buffer [20 mM Tris-HCl (pH 7.4), 10 mM NaCl, 1 mM EDTA, 1 mM ethylene glycol-O-O′-bis(2-amino-ethyl)-N,N,N′,N′-tetraacetic acid (EGTA), 0.1 mM phenylmethylsulfonyl fluoride, protease inhibitor cocktail and 1% Triton X-100], the cells were lysed on ice. The lysates were subsequently centrifuged at 10,000 × g for 20 min at 4°C and the supernatants were loaded on 15% sodium dodecyl sulphate-polyacrylamide gel electrophoresis gel and transferred to a nitrocellulose membrane. The membranes were subsequently immunoblotted with various primary antibodies and incubated with the respective peroxidase-conjugated secondary antibodies. The signals were visualized using an enhanced ECL kit from Amersham Pharmacia Biotech.

Statistical analysis

Experiments were performed at least three times. Statistical significance was analyzed using a Student's t-test (two-tailed). P<0.05 was considered to indicate a statistically significant difference.

Results

Inhibitory effects of capsaicin on the cell viability of osteosarcoma cells

We examined the effects of capsaicin in the MG63 osteosarcoma cell lines, which had been treated with various concentrations of capsaicin (0, 50, 100, 150, 200, 250 and 400 μM) for various time-periods (0, 3, 6, 12, 24 and 48 h). As shown in Fig. 1, capsaicin reduced the viability of the MG63 cells in a dose- and time-dependent manner, as demonstrated using MTT (Fig. 1A and C) and trypan blue exclusion (Fig. 1B and D) assays. The viability of the cells treated with 150 μM capsaicin for 24 h was markedly reduced.

MG63 cell morphology observed using light microscopy

MG63 cells were cultured for 24 h with different concentrations of capsaicin (0, 50, 100, 150, 250 and 400 μM). Following 24 h treatment with capsaicin, no significant morphological changes were observed in the cells treated with capsaicin at 50 and 100 μM. However, the cells exhibited the morphological features of apoptosis when treated with 150 μM capsaicin for 24 h (Fig. 2). These morphological changes of the cells represented the apoptotic cell death that occurred with 150 μM capsaicin at the end of the 24-h exposure.

Capsaicin-induced apoptosis in MG63 cells

In order to characterize the type of cell death that had been observed, we examined whether the cell death was apoptosis. MG63 cells were treated with 150 μM capsaicin for 24 h and the apoptotic DNA fragmentation of the MG63 cells was visualized using TUNEL assay. TUNEL assay is a tool that is frequently used for the detection of DNA fragmentation (18,19). The significant increase in the number of TUNEL-positive cells (green) showed that capsaicin induced apoptosis in the MG63 cells (Fig. 3A). In addition, as shown in Fig. 3B, capsaicin treatment resulted in an increased proportion of cells in the G0–G1 phase, from 0.26 to 24.8%. The G0–G1 phase is an indicator for cell apoptosis when increased. These results suggested that capsaicin induced apoptosis.

To investigate the effect of capsaicin on protein molecules that are involved in apoptosis, western blot analysis was used to test for the presence of the anti-apoptotic proteins Bcl-2 and cleaved caspase 3 (pro-caspase-3) and the pro-apoptotic protein Bax. MG63 cells were treated with various concentrations of capsaicin for 24 h and with 150 μM capsaicin for different time-periods. Capsaicin decreased the expression of pro-caspase-3 and Bcl-2, while the expression of Bax was increased in a dose- and time-dependent manner (Fig. 4A and B).

Identifying the signaling pathway that regulates the capsaicin-induced cell death

It has been demonstrated that apoptosis leads to various signaling processes and, among them, the mitogen-activated protein kinases (MAPKs) (20), the caspase cascade (21) and the antioxidant enzyme system (22) are the major executors of the process of apoptosis. We initially suggested that the MAPK signaling pathway was involved in the capsaicin-induced apoptosis. However, the group that was pretreated with MAPK inhibitor did not show any differences when compared with the group treated only with capsaicin using MTT assay and western blot analysis (Fig. 5). The data demonstrated that capsaicin-induced apoptosis was not regulated by the MAPK signaling pathway in MG63 cells. The involvement of the caspase cascade in the capsaicin-induced apoptosis using MTT assay, trypan blue exclusion, western blot analysis and flow cytometry was then examined. Consistently, it was shown that the general caspase cascade inhibitor, Z-VAD-FMK, had some effect when the results were compared with those from the group treated only with capsaicin (Fig. 6). These results suggested that the caspase cascade was involved in capsaicin-induced apoptosis. In addition, the antioxidant enzyme system was demonstrated to be involved in the capsaicin-induced apoptosis. In the groups that were pretreated with antioxidant enzyme inhibitor, the viability of the MG63 cells decreased from 24.08 to 7.86% [N-acetyl-L-cysteine (NAC)] and 13.88% (catalase) compared with the group treated only with capsaicin. This result showed that antioxidant enzyme inhibitors affected the apoptosis using a variety of methods (Fig. 7). We demonstrated that antioxidant enzymes were involved in the capsaicin-induced apoptosis in MG63 cells.

Discussion

In this study, we used a variety of techniques and demonstrated that the cell viability of MG63 cells was able to be reduced by capsaicin in a dose- and time-dependent manner. In addition, the capsaicin-treated group showed an increased level of positivity with the TUNEL assay and an increase in Bax protein. Moreover, the experiments with the signaling pathway inhibitors showed that the groups pretreated with Z-VAD-FMK, NAC and catalase, respectively, had different results compared with those from the group treated only with capsaicin. These results indicated that the capsaicin-induced apoptosis in MG63 cells may have been mediated by the caspase cascade and the antioxidant enzyme system, among various signaling pathways.

Osteosarcoma is the most frequently occurring primary malignant neoplasms of the long bones, including the distal femur and the proximal humerus, and mainly affects children and adolescents (10,23). The prognosis for osteosarcoma, for which conventional treatments include surgery, chemotherapy and radiotherapy, is poor due to the early pulmonary metastasis and limited improvements. Chemotherapy has become a foundation for the basic treatment of osteosarcoma. A number of studies have focused on the development of new effective therapeutic strategies for osteosarcoma, using novel materials extracted from natural food substances that exhibit an anticancer effect, despite the successful use of neoadjuvant chemotherapy in the treatment of osteosarcoma (11,12,15,24).

It has been demonstrated that a number of reagents are able to induce apoptosis on MG63 human osteosarcoma cells (2527); however, the effect of capsaicin on MG63 cells has remained unclear. Capsaicin, the main pungent ingredient in the genus Capsicum, has long been used in drugs for weight loss and has been studied as an attractive drug for cancer treatment, as an agent that induces apoptosis in various cell types in vitro(2831). Moreover, the compound has been indicated to promote apoptosis in vivo as the mechanism of tumor cell elimination in animal models for carcinogenesis (32,33). These observations have continued to draw attention to capsaicin as a possible anticancer agent.

Apoptosis has been suggested as a promising target for cancer chemotherapy (3436). Apoptosis is a form of self-regulated cell death and occurs during normal cell turnover, development and immune regulation (37,38). The characteristic morphological changes involved in apoptosis include cytoplasmic shrinkage, plasma membrane blebbing, chromatin condensation and the formation of apoptotic bodies containing well-preserved organelles. In addition, during apoptosis cells undergo double-strand cleavage of nuclear DNA (34,3941).

This study was designed to investigate capsaicin-induced apoptosis in MG63 human osteosarcoma cells and its underlying molecular mechanisms. Using TUNEL assay, flow cytometric assay and western blot analysis, we demonstrated that the anticancer effect of capsaicin resulted in morphological changes, decreased cell viability and apoptosis in the MG63 cells (Figs. 14). These results showed that capsaicin was able to inhibit cell viability and growth and induce apoptosis.

We investigated the molecular factors that were involved in the apoptosis of capsaicin-treated MG63 cells. The MAPKs are expressed in all mammalian cell types and have individually different functions in the regulation of specific cell responses. MAPKs have been demonstrated to be composed of three parallel kinase modules, including ERK, JNK and p-38-MAPK (4244). As shown in numerous studies, the MAPK signaling pathway is important in the regulation of cellular growth, differentiation, survival, angiogenesis and apoptosis (20,45,4648). Accordingly, we initially suggested that the MAPK signaling pathway was involved in the cellular response of capsaicin-induced apoptosis. Using groups pretreated with MAPK inhibitors, it was revealed that MAPKs exerted no specific effect in capsaicin-induced apoptosis in the MG63 cells (Fig. 5).

It has been revealed that caspase, or cysteine-aspartic protease, belongs to the group of enzymes known as cysteine proteases, which are homologous to the Caenorhabditis elegans, the cell death gene, CED-3 (21,49). Cysteine proteases have multi-faceted functions in virtually every aspect of physiology, such as in growth and development, senescence and apoptosis (50,51). Moreover, the components of the caspase cascade are present in various cells in the form of inactive zymogens, which are then activated to convey the apoptotic signal (52). Furthermore, it has been suggested that the caspase cascade may induce the apoptotic reaction (53). Our results showed that the caspase cascade regulated capsaicin-induced apoptosis, observed through cell viability, western blot analysis and flow cytometry (Fig. 6).

In present study it was demonstrated that the antioxidant enzyme system was also involved in the capsaicin-induced apoptosis. The antioxidant enzyme system has been indicated to be important in the control of apoptosis (54,55). In addition, antioxidant enzymes defend cells from oxidative damage, such as reactive oxygen species (ROS) production (5658). ROS interact with a wide range of cell components and cause damage to cell structures, including the membrane, and are regulated with apoptosis (30,5961). As such, antioxidant enzymes have the potential to protect the cells from oxidative damage. Based on the results of our study, we verified that the antioxidant enzyme system was particularly effective in capsaicin-induced apoptosis in the MG63 cells, as demonstrated using a variety of methods (Fig. 7). Therefore, it was indicated that ROS were part of the capsaicin-induced apoptosis pathway in the MG63 cells.

The present study provided distinct results describing the effect of capsaicin on MG63 cells, in addition to elucidating the molecular mechanisms that were implicated in the indution of apoptosis. In combination, the results showed that capsaicin induced apoptosis in the MG63 cells and that the caspase cascade and antioxidant enzyme system were the underlying regulatory signaling pathways involved in the capsaicin-induced apoptosis. In a previous study, we demonstrated the effect of capsaicin on human glioblastoma U87MG cells and concluded that capsaicin induced apoptosis in the U87MG cells (62). The present results indicated that capsaicin exhibited an anticancer effect in osteosarcoma cells. Further in vitro and in vivo studies are required before capasaicin is able to be ultimately applied to treat human patients with osteosarcoma.

Acknowledgements

This study was supported by a grant from the SNUBH Research Fund (grant no. 02-2012-036).

References

1 

Firdous AP, Sindhu ER, Ramnath V and Kuttan R: Anti-mutagenic and anti-carcinogenic potential of the carotenoid meso-zeaxanthin. Asian Pac J Cancer Prev. 11:1795–1800. 2010.PubMed/NCBI

2 

Patel D, Shukla S and Gupta S: Apigenin and cancer chemoprevention: Progress potential and promise (Review). Int J Oncol. 30:233–245. 2007.PubMed/NCBI

3 

Weisburger JH: Antimutagens, anticarcinogens, and effective worldwide cancer prevention. J Environ Pathol Toxicol Oncol. 18:85–93. 1999.PubMed/NCBI

4 

Cordell GA and Araujo OE: Capsaicin: identification, nomenclature, and pharmacotherapy. Ann Pharmacother. 27:330–336. 1993.PubMed/NCBI

5 

Stavric B: Role of chemopreventers in human diet. Clin Biochem. 27:319–332. 1994. View Article : Google Scholar : PubMed/NCBI

6 

Huang SP, Chen JC, Wu CC, et al: Capsaicin-induced apoptosis in human hepatoma HepG2 cells. Anticancer Res. 29:165–174. 2009.PubMed/NCBI

7 

Kim CS, Park WH, Park JY, et al: Capsaicin, a spicy component of hot pepper, induces apoptosis by activation of the peroxisome proliferator-activated receptor gamma in HT-29 human colon cancer cells. J Med Food. 7:267–273. 2004. View Article : Google Scholar

8 

Chang HC, Chen ST, Chien SY, Kuo SJ, Tsai HT and Chen DR: Capsaicin may induce breast cancer cell death through apoptosis-inducing factor involving mitochondrial dysfunction. Hum Exp Toxicol. 30:1657–1665. 2011. View Article : Google Scholar

9 

Baek YM, Hwang HJ, Kim SW, et al: A comparative proteomic analysis for capsaicin-induced apoptosis between human hepatocarcinoma (HepG2) and human neuroblastoma (SK-N-SH) cells. Proteomics. 8:4748–4767. 2008. View Article : Google Scholar : PubMed/NCBI

10 

Enneking WF and Springfield DS: Osteosarcoma. Orthop Clin North Am. 8:785–803. 1977.

11 

Ferguson WS and Goorin AM: Current treatment of osteosarcoma. Cancer Invest. 19:292–315. 2001. View Article : Google Scholar : PubMed/NCBI

12 

Bacci G and Lari S: Adjuvant and neoadjuvant chemotherapy in osteosarcoma. Chir Organi Mov. 86:253–268. 2001.PubMed/NCBI

13 

Biermann JS and Baker LH: The future of sarcoma treatment. Semin Oncol. 24:592–597. 1997.PubMed/NCBI

14 

La Quaglia MP: Osteosarcoma. Specific tumor management and results. Chest Surg Clin N Am. 8:77–95. 1998.PubMed/NCBI

15 

Marina N, Gebhardt M, Teot L and Gorlick R: Biology and therapeutic advances for pediatric osteosarcoma. Oncologist. 9:422–441. 2004. View Article : Google Scholar : PubMed/NCBI

16 

Papagelopoulos PJ, Galanis EC, Vlastou C, et al: Current concepts in the evaluation and treatment of osteosarcoma. Orthopedics. 23:858–867; quiz 868–869. 2000.PubMed/NCBI

17 

Yang C, Ji D, Weinstein EJ, et al: The kinase Mirk is a potential therapeutic target in osteosarcoma. Carcinogenesis. 31:552–558. 2010. View Article : Google Scholar : PubMed/NCBI

18 

Wieder R: TUNEL assay as a measure of chemotherapy-induced apoptosis. Methods Mol Med. 111:43–54. 2005.PubMed/NCBI

19 

Rohwer F and Azam F: Detection of DNA damage in prokaryotes by terminal deoxyribonucleotide transferase-mediated dUTP nick end labeling. Appl Environ Microbiol. 66:1001–1006. 2000. View Article : Google Scholar : PubMed/NCBI

20 

Dhanasekaran DN and Johnson GL: MAPKs: function, regulation, role in cancer and therapeutic targeting. Oncogene. 26:3097–3099. 2007. View Article : Google Scholar : PubMed/NCBI

21 

Cohen GM: Caspases: the executioners of apoptosis. Biochem J. 326:1–16. 1997.

22 

Kong Q and Lillehei KO: Antioxidant inhibitors for cancer therapy. Med Hypotheses. 51:405–409. 1998. View Article : Google Scholar

23 

Delling G: Diagnosis of bone tumors. Verh Dtsch Ges Pathol. 82:121–132. 1998.(In German).

24 

Federman N, Bernthal N, Eilber FC and Tap WD: The multidisciplinary management of osteosarcoma. Curr Treat Options Oncol. 10:82–93. 2009. View Article : Google Scholar

25 

De Luna-Bertos E, Ramos-Torrecillas J, Garcia-Martinez O, Diaz-Rodriguez L and Ruiz C: Effect of aspirin on cell growth of human MG-63 osteosarcoma line. Scientific World Journal. 2012:8342462012.PubMed/NCBI

26 

Lin KL, Chi CC, Lu T, et al: Effect of sertraline on [Ca2+]i and viability of human MG63 osteosarcoma cells. Drug Chem Toxicol. 36:231–240. 2013.

27 

Jin S, Shen JN, Wang J, Huang G and Zhou JG: Oridonin induced apoptosis through Akt and MAPKs signaling pathways in human osteosarcoma cells. Cancer Biol Ther. 6:261–268. 2007. View Article : Google Scholar : PubMed/NCBI

28 

Wu CC, Lin JP, Yang JS, et al: Capsaicin induced cell cycle arrest and apoptosis in human esophagus epidermoid carcinoma CE 81T/VGH cells through the elevation of intracellular reactive oxygen species and Ca2+productions and caspase-3 activation. Mutat Res. 601:71–82. 2006. View Article : Google Scholar

29 

Ip SW, Lan SH, Huang AC, et al: Capsaicin induces apoptosis in SCC-4 human tongue cancer cells through mitochondria-dependent and -independent pathways. Environ Toxicol. 27:332–341. 2012. View Article : Google Scholar : PubMed/NCBI

30 

Yang ZH, Wang XH, Wang HP, Hu LQ, Zheng XM and Li SW: Capsaicin mediates cell death in bladder cancer T24 cells through reactive oxygen species production and mitochondrial depolarization. Urology. 75:735–741. 2010. View Article : Google Scholar : PubMed/NCBI

31 

Zhang R, Humphreys I, Sahu RP, Shi Y and Srivastava SK: In vitro and in vivo induction of apoptosis by capsaicin in pancreatic cancer cells is mediated through ROS generation and mitochondrial death pathway. Apoptosis. 13:1465–1478. 2008. View Article : Google Scholar : PubMed/NCBI

32 

Mori A, Lehmann S, O'Kelly J, et al: Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells. Cancer Res. 66:3222–3229. 2006. View Article : Google Scholar : PubMed/NCBI

33 

Bai H, Li H, Zhang W, et al: Inhibition of chronic pancreatitis and pancreatic intraepithelial neoplasia (PanIN) by capsaicin in LSL-KrasG12D/Pdx1-Cre mice. Carcinogenesis. 32:1689–1696. 2011. View Article : Google Scholar : PubMed/NCBI

34 

Wong RS: Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res. 30:872011. View Article : Google Scholar : PubMed/NCBI

35 

Yue TL, Ohlstein EH and Ruffolo RR Jr: Apoptosis: a potential target for discovering novel therapies for cardiovascular diseases. Curr Opin Chem Biol. 3:474–480. 1999. View Article : Google Scholar : PubMed/NCBI

36 

Kerr JF, Wyllie AH and Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26:239–257. 1972. View Article : Google Scholar : PubMed/NCBI

37 

Elmore S: Apoptosis: a review of programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI

38 

Lawen A: Apoptosis - an introduction. Bioessays. 25:888–896. 2003. View Article : Google Scholar

39 

Nagata S: DNA degradation in development and programmed cell death. Annu Rev Immunol. 23:853–875. 2005. View Article : Google Scholar : PubMed/NCBI

40 

Zhivotosky B and Orrenius S: Assessment of apoptosis and necrosis by DNA fragmentation and morphological criteria. Curr Protoc Cell Biol. Chapter 18(Unit 18): 132001.PubMed/NCBI

41 

Negoescu A, Guillermet C, Lorimier P, Brambilla E and Labat-Moleur F: Importance of DNA fragmentation in apoptosis with regard to TUNEL specificity. Biomed Pharmacother. 52:252–258. 1998. View Article : Google Scholar : PubMed/NCBI

42 

Seger R and Krebs EG: The MAPK signaling cascade. FASEB J. 9:726–735. 1995.PubMed/NCBI

43 

Raman M, Chen W and Cobb MH: Differential regulation and properties of MAPKs. Oncogene. 26:3100–3112. 2007. View Article : Google Scholar : PubMed/NCBI

44 

Lee S, Lee HS, Baek M, et al: MAPK signaling is involved in camptothecin-induced cell death. Mol Cells. 14:348–354. 2002.PubMed/NCBI

45 

Ren D, Yang H and Zhang S: Cell death mediated by MAPK is associated with hydrogen peroxide production in Arabidopsis. J Biol Chem. 277:559–565. 2002. View Article : Google Scholar : PubMed/NCBI

46 

Zohrabian VM, Forzani B, Chau Z, Murali R and Jhanwar-Uniyal M: Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation. Anticancer Res. 29:119–123. 2009.PubMed/NCBI

47 

Mavria G, Vercoulen Y, Yeo M, et al: ERK-MAPK signaling opposes Rho-kinase to promote endothelial cell survival and sprouting during angiogenesis. Cancer Cell. 9:33–44. 2006. View Article : Google Scholar : PubMed/NCBI

48 

Roux PP and Blenis J: ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev. 68:320–344. 2004. View Article : Google Scholar : PubMed/NCBI

49 

Thornberry NA: The caspase family of cysteine proteases. Br Med Bull. 53:478–490. 1997. View Article : Google Scholar : PubMed/NCBI

50 

Li X, Su B, Liu R, Wu D and He D: Tetrandrine induces apoptosis and triggers caspase cascade in human bladder cancer cells. J Surg Res. 166:e45–e51. 2011. View Article : Google Scholar : PubMed/NCBI

51 

Fan TJ, Han LH, Cong RS and Liang J: Caspase family proteases and apoptosis. Acta Biochim Biophys Sin (Shanghai). 37:719–727. 2005. View Article : Google Scholar : PubMed/NCBI

52 

Denault JB and Salvesen GS: Caspases: keys in the ignition of cell death. Chem Rev. 102:4489–4500. 2002. View Article : Google Scholar : PubMed/NCBI

53 

Desouza M, Gunning PW and Stehn JR: The actin cytoskeleton as a sensor and mediator of apoptosis. Bioarchitecture. 2:75–87. 2012. View Article : Google Scholar : PubMed/NCBI

54 

Kannan K and Jain SK: Oxidative stress and apoptosis. Pathophysiology. 7:153–163. 2000. View Article : Google Scholar

55 

Mates JM, Perez-Gomez C and Nunez de Castro I: Antioxidant enzymes and human diseases. Clin Biochem. 32:595–603. 1999. View Article : Google Scholar : PubMed/NCBI

56 

Bostwick DG, Alexander EE, Singh R, et al: Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer. Cancer. 89:123–134. 2000. View Article : Google Scholar : PubMed/NCBI

57 

Circu ML and Aw TY: Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med. 48:749–762. 2010. View Article : Google Scholar : PubMed/NCBI

58 

Stadtman ER: Role of oxidant species in aging. Curr Med Chem. 11:1105–1112. 2004. View Article : Google Scholar : PubMed/NCBI

59 

Bechtel W and Bauer G: Catalase protects tumor cells from apoptosis induction by intercellular ROS signaling. Anticancer Res. 29:4541–4557. 2009.PubMed/NCBI

60 

Inoue M, Sakaguchi N, Isuzugawa K, Tani H and Ogihara Y: Role of reactive oxygen species in gallic acid-induced apoptosis. Biol Pharm Bull. 23:1153–1157. 2000. View Article : Google Scholar : PubMed/NCBI

61 

Gao F, Yi J, Yuan JQ, Shi GY and Tang XM: The cell cycle related apoptotic susceptibility to arsenic trioxide is associated with the level of reactive oxygen species. Cell Res. 14:81–85. 2004. View Article : Google Scholar : PubMed/NCBI

62 

Cha JH, Choi YJ, Cha SH, Choi CH and Cho WH: Allicin inhibits cell growth and induces apoptosis in U87MG human glioblastoma cells through an ERK-dependent pathway. Oncol Rep. 28:41–48. 2012.PubMed/NCBI

Related Articles

Journal Cover

December 2013
Volume 8 Issue 6

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Cho WH, Lee HJ, Choi YJ, Oh JH, Kim HS and Cho HS: Capsaicin induces apoptosis in MG63 human osteosarcoma cells via the caspase cascade and the antioxidant enzyme system. Mol Med Rep 8: 1655-1662, 2013
APA
Cho, W.H., Lee, H.J., Choi, Y.J., Oh, J.H., Kim, H.S., & Cho, H.S. (2013). Capsaicin induces apoptosis in MG63 human osteosarcoma cells via the caspase cascade and the antioxidant enzyme system. Molecular Medicine Reports, 8, 1655-1662. https://doi.org/10.3892/mmr.2013.1737
MLA
Cho, W. H., Lee, H. J., Choi, Y. J., Oh, J. H., Kim, H. S., Cho, H. S."Capsaicin induces apoptosis in MG63 human osteosarcoma cells via the caspase cascade and the antioxidant enzyme system". Molecular Medicine Reports 8.6 (2013): 1655-1662.
Chicago
Cho, W. H., Lee, H. J., Choi, Y. J., Oh, J. H., Kim, H. S., Cho, H. S."Capsaicin induces apoptosis in MG63 human osteosarcoma cells via the caspase cascade and the antioxidant enzyme system". Molecular Medicine Reports 8, no. 6 (2013): 1655-1662. https://doi.org/10.3892/mmr.2013.1737